Karuna Therapeutics Sees Breakthrough In Schizophrenia Drug
Karuna Therapeutics' top-experimental schizophrenia drug significantly reduced symptoms in a late-stage trial but there were concerns that it could cause hypertension in patients.
The North American wolverine will receive long-delayed federal protections under a Biden administration proposal released Wednesday in response to scientists warning that climate change will likely melt away the rare species’ snowy mountain refuges.